Investing Profile

Oliver Reuss

InvestorVC
Executive Director / Investment Manager; Boehringer Ingelheim Venture Fund at Boehringer Ingelheim Venture Fund
Photo of Oliver Reuss, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Washington Applied Physics Laboratory Network
837 CONNECTIONS
Self-Employed Network
771 CONNECTIONS
Calling Brands Network
656 CONNECTIONS
HTGF | High-Tech Gründerfonds Network
47 CONNECTIONS
ZS Network
29 CONNECTIONS
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
Brainomix
Series CMar 2025$18M
Series BDec 2021$21M
$59M
Co-investors: Sahir Ali (Draper Associates), Alastair Kilgour (Parkwalk Advisors), John Pearson (Parkwalk Advisors)
Perfood
Series ANov 2020$6M
$6M
Co-investors: Michael Lütolf (MY BENI)
Postdoc Self-EmployedPresent
Postdoc Calling BrandsPresent
Postdoc University of Washington Applied Physics LaboratoryPresent
Business Analyst ZSPresent
International Business Analysis Manager Boehringer IngelheimPresent
Senior Manager PM Strategy & Portfolio Management Boehringer IngelheimPresent
Head of Prescription Medicine Strategy & Strategic Intelligence Boehringer IngelheimPresent
Head of Business Model & HealthCare Innovation Boehringer IngelheimPresent
Member, Board of Directors Diabetestyp2 glucuraPresent
Executive Director / Investment Manager; Boehringer Ingelheim Venture Fund Boehringer IngelheimPresent
Member, Board of Directors DopavisionPresent
Member, Board of Directors BrainomixPresent
Observer, Board of Directors GLOX Therapeutics Ltd.Present
Member, Board of Directors AignosticsPresent
Member, Board of Directors C-mo Medical SolutionsPresent
Member of the Investment Committee HTGF | High-Tech GründerfondsPresent
Bayerische Julius-Maximillians University of Würzburg Diploma Biology, General
Bayerische Julius-Maximillians University of Würzburg Dr. rer. nat. / PhD Molecular Biology
Sign in with Google →
Sign in with Google →